Health Care • Medical/Dental Instruments
$80.94 ▼ -4.33
(-5.08%)
MKT CAP: $1.95B • VOL: 427.4K
52W L $78 52W H $118
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$68
MEDIAN
$91
MEAN
$92
HIGH
$110
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE LMAT TAPE
LMAT // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $97.94 | $93.08 | 2025-02-14 | $73.66 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $101.98 | $95.51 | 2025-02-06 | $76.08 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $92.27 | $89.03 | 2025-01-29 | $77.70 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $82.56 | — | 2025-01-17 | $79.32 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $71.23 | $76.89 | 2025-01-09 | $72.04 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $96.32 | $84.18 | 2024-12-18 | $70.42 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $78.51 | $81.75 | 2024-12-04 | $75.27 | -4.3% | 48% | C |